semaglutide to tirzepatide dose conversion Switching from dosage chart Switching Between Semaglutide and Tirzepatide:

The concentration should be printed on the vial label, typically expressed as "X mg/mL" (for example, "5 mg/mL" or "2.5 mg/mL")

Since then, several GLP-1s for obesity have been approved for new indications such as secondary cardiovascular risk reduction (Wegovy), sleep apnea (Zepbound) and metabolic dysfunction-associated steatohepatitis or MASH (Wegovy)

Interestingly, TG and apoB48 levels rapidly rise in the 2 h following the second meal in these patients to levels similar as pre-treatment responses ( Genetic elimination of Itgb7 in mice decreases the expression of Glp1r on and T cells yet increases fasting plasma GLP-1, intestinal Gcg mRNA expression, and ileal L cell abundance ( In vitro experiments reveal GLP-1 concentration in media after 24 h of co-incubation of GLUTag cells with and T cells negatively associate with the level of Glp1r expression in the latter cells ( Glp1r expressing and T cells can further decrease GLP-1 concentration in media from GLUTag cells in the presence of exendin-4, suggesting that Glp1r- expressing and T cells act as a sink for local GLP-1 production ( Glp1r / mice ( ex vivo , where media GLP-1 concentration from ileal tissue from Itgb7 / mice is significantly higher than in the media from wild-type tissue, and this increase can be replicated in wild-type tissue upon GLP-1R antagonist (exendin-9) treatment ( GLP-2R Subcutaneous injection (15,000 g) of GLP-2 5 h after the start of a liquid mixed macronutrient formula infusion through a nasoduodenal tube in healthy men significantly increases peak plasma TG and TRL-apoB48 at 1 h and area under the concentration curve for the first 3 h of treatment ( Glp2r / mice display increased fasting and 10 min post-olive oil gavage plasma active GLP-1 compared to wild-type controls, despite similar fasting DPP4 activity levels in circulation ( 3 H-triolein) reveal that GLP-2 increases the radiolabel incorporation into plasma TG at 60- and 90-min post-gavage with no differences observed in plasma cholesterol compared to control ( Cd36 / mice compared to wild-type controls ( Cd36 / mice compared to saline control ( 35 S-methionine pulse-chase experiments of jejunal fragments isolated hamsters 1 h after an olive oil gavage reveal that GLP-2 treatment ex vivo increases the secretion of the radiolabelled-apoB48 into the media with unchanged cellular concentrations

"98% patient success rate" - Source: Sunlight's official website

BTIG analysts Marie Thibault and Sam Eiber seem to agree with that sentiment on a broader scale

The reason for the observed BP reduction with SGLT-2 inhibitors involves several pathways including a modest diuretic effect (54), weight reduction and potentially some sodium depletion (55)